{"name":"QOL Medical, LLC","slug":"qol-medical-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Sucraid","genericName":"Sucraid","slug":"sucraid","indication":"Sucrase-isomaltase deficiency","status":"marketed"}]}],"pipeline":[{"name":"Sucraid","genericName":"Sucraid","slug":"sucraid","phase":"marketed","mechanism":"Small molecule","indications":["Sucrase-isomaltase deficiency"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPNkk4ZlpSUXlPVWVQVnJDSWRpR2pCTEowZjVjOEVxZExPQXBqRGFXREhMcjJRTW0tOWVxVHFxNWRzNDk4OUVLQ0tUN05LeUI3YzV6Q0RjOUJaR05weDZPU2lLaVVFejFrNEhLWXhwZ19LbVprOGN5b2dEVTkwZ1h4dTRMVnAySnVPUEp3QUcyY002cld2a1haeU5FN3A3M1hjTmJsczZReW4wNHBSQ1hUeW42OG9JMXVIZUp1UQ?oc=5","date":"2025-12-17","type":"patent","source":"prnewswire.com","summary":"Evoke Pharma and QOL Medical Announce Expiration of Tender Offer - prnewswire.com","headline":"Evoke Pharma and QOL Medical Announce Expiration of Tender Offer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPZGlzU0pnQzhjb3FMcEVXLWVaWVB6MVh4aXlxSzIzRWF6WnBpZmtDekVLSWRad3pYWU5GSHIycWk5TjVJTlVmci1sWWZLblJQOGhRNEJGcnNHWERKM1JxOXlvWDh0NFdCTEVWb2M2aDg3X24tNkZMdDVoTUxrcXJtU2ZQVnNSenZScTI4UkI0dHV3UEx2YkpDUWs5NEdzWWI4YWZTeXhzTjBqcU9QR0lhd1IyVQ?oc=5","date":"2025-12-17","type":"pipeline","source":"Stock Titan","summary":"Evoke Pharma investors get $11 a share as the company leaves Nasdaq - Stock Titan","headline":"Evoke Pharma investors get $11 a share as the company leaves Nasdaq","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOQ05rRkZ5VV82cjFHVlRNRzBwSkdRNHRadkZwODBBX2ltUUQ1Q29lU0lTbWoyYzIya0RfQ3E0NUw4WXMwQXZ3bk85WjFKdEMxbWlEVk5lUEE2NVFBNUxvYTF0dHEwanZMRTJkX25CYU56R3ZyRUpMNFhyLU5iNm5PeDN5dC13WnBTTUx0Qy1OY1NUcDFCQ3Jod05BbGdKbTZEZUFPU09ubTBKVzNSRGhFcHdxOW9iY205MXFJXy1QaG13enA4?oc=5","date":"2025-12-17","type":"deal","source":"Investing.com","summary":"Evoke Pharma acquired by QOL Medical, shares to be delisted from Nasdaq - Investing.com","headline":"Evoke Pharma acquired by QOL Medical, shares to be delisted from Nasdaq","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPTzRfQ3RQc0VIMG01M3VHdm5QdVc0ZDNJS0pGZjFPcHB0Z21VTkZOenlUcmRRcWhMd3VqaGgxeVk3dk5WbmZla1RNRjdVY242MDNmUXJRclB4d0x6bTVHcFI5Sk9PWnpvN25pZ1FHcnpHR0l5akV5UC1NZDExdmU2WEVZOE1ZSWw1UWFxQm5WYw?oc=5","date":"2025-11-04","type":"pipeline","source":"Latham & Watkins LLP","summary":"Latham & Watkins Advises Evoke Pharma on Acquisition by QOL Medical - Latham & Watkins LLP","headline":"Latham & Watkins Advises Evoke Pharma on Acquisition by QOL Medical - Latham & Watkins LLP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxNX0xDSFB5TFZtNk51MXNRT0Z1b1hDOG5RWGh4elliYTFuVE9hX2FjWTZrTEdmWmtoNF9scWZ5OFN6cUZGNjhGRTZEMW9MWlpYR2otc2FiZWZKdERxY3J0Y2IzdG1vSEliNGwtRWl0T183bDJTNFk3ZExncFh6c1JSNU5DMlU5bzJ0cTJuT3gwZHFCT01GRjdDM1VvWnBrWVJOY0ZOZ01WZDhmVllreVUwWDRFNXhXb2xNb0NCVUVNaTdCQVhDamxyY2VPem84TnpTdzZkNmVMQkhhaGpvcTRtUWpVQktjQQ?oc=5","date":"2025-11-04","type":"deal","source":"GlobeNewswire","summary":"Evoke Pharma Enters into Definitive Agreement to Be Acquired by QOL Medical - GlobeNewswire","headline":"Evoke Pharma Enters into Definitive Agreement to Be Acquired by QOL Medical","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxQWlJVTEJ3S3J0NWFSUlhxNVRpRE15QzNtNnM4WEQ1a25RSGZxcFdWcnY3UUhKU0VQVWN2d3I5NnFvMlFlU1ctMzlFd2ctQUpBcF9JdWdhbXVOZFBxMlBkdEI2YktTUkpkYUxUanM1MVVJOTMwMG9zSHRmRTBUT09Lc3p4SEh5V1Rkd3VLbGJadDR2NEJLR2RZakRVNVdWTFc3Ymh3TzBUbjVld013RTdMS1d5QURaSklMcXo3d3VTLURXSmNDRmhNbGpQMGNCWUR1TVZHQ2liQlVTN1Y2WmZmOWlpTHhveTY0TzZ6ck5na3VvUkVrajNpSFZiTEN5dw?oc=5","date":"2025-11-04","type":"pipeline","source":"businesswire.com","summary":"EVOK Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Evoke Pharma, Inc. is Fair to Shareholders - businesswire.com","headline":"EVOK Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Evoke Pharma, Inc. is Fair to Shareholders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQLUx5Y3pFeVNOQl9EZW80WnZLYkVCa0U0ZHJJYUJOYjV0Y1pSd3dJUmNTaWJCaXpWMnctTjBFc1M0WExKalNkMWQ1WGZJRTVaaGUzSTlJbldZTU5QV2pZVDdLdXZ2UEdMVHVfUUp2WGRCeUtPRVB3LUdxLXVpdS0wdi12UEFLbUl1WnhtWXYwV2lOSEpWa2JKbi16cm91b1o5bEFTaU5Pa0Y4NXo5SEZSanhTUlozNEZMZklWZ0dDdw?oc=5","date":"2025-11-04","type":"deal","source":"Investing.com","summary":"QOL Medical to acquire Evoke Pharma for $11 per share in cash deal - Investing.com","headline":"QOL Medical to acquire Evoke Pharma for $11 per share in cash deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPdzVUdWg5R0NEbnJjblI2U25OZU1mRjAxYWtxY3NDelVMTXp3aGRUWEZwNlVxSWlGUk9nVnBxcVB2UG0xR1duWmU3LXlmNVNINkhuMWZ1bnEtU3l1a3JJbXV4MU1IdmtBa1drM0ppOVI5QURJZXFZN0Rla0NITVdmUkszRWhzVGNTYjFiNDl5YW1HNDZ3c09PVlN4aFJqanJNNWdKZFBhMjJKZE9xUmxqTFoxcw?oc=5","date":"2025-11-04","type":"deal","source":"Stock Titan","summary":"QOL Medical to launch tender offer for Evoke Pharma under merger pact - Stock Titan","headline":"QOL Medical to launch tender offer for Evoke Pharma under merger pact","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOMExqdXcxSWVJajVBdm1xUS11ZmZacHoxLU9KaDFmaFNNZTAyeGdiNWpNVzJQNUgwVVFmckNyY3FDb180bFNtbFpHNGhMczJKZWVsWXlndlBRUF9CaWYyTzMwTWNLSnlhNlRYRU5JTk5mdVIxM1BQWXpiVHR0S1c5MlNDdTlkNUhRN04xWjRBOTdXcEpoZUpDMm4xYUlPQVFZOF9ULWRtekZha2ZScUlqRVdOUjU1em1WMXpJMXpsbndyV24wODdDNERjZTQ0MEV0RVE?oc=5","date":"2025-05-16","type":"pipeline","source":"prnewswire.com","summary":"Derick Cooper, CEO of QOL Medical, Donates $7 Million to Transform Higher Education - prnewswire.com","headline":"Derick Cooper, CEO of QOL Medical, Donates $7 Million to Transform Higher Education","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2024-11-19","type":"pipeline","source":"Whistleblower Network News","summary":"Whistleblowers’ Allegations of Kickbacks Results in $47 Million False Claims Act Settlement - Whistleblower Network News","headline":"Whistleblowers’ Allegations of Kickbacks Results in $47 Million False Claims Act Settlement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwJBVV95cUxOMVo3UjM5d1RYOW11S0FEbnBKNTBVQkxkeEgzRkJmeWtXby13WGYtY003RlFkWVltektsa081RFFrNEFpdWI5RmpacG8tYjIxUlZzOFlRUWxNS1hOWDcwNF9pd0JiakNZTmxrNzNkbTFSLUhmdzNYMUlpYy1sTWdxbkc2NFJYVmxLTVNobk9wNTlFdzhXdV9tQmlfbVVHTU9TV2tGMmZQR0xwVFRaUEl6eGxMV3NOalgxNUpZaWpqSUdjMXYtenY0Z3hsZU1VNmgtODhZVzhZc28xVXhZS3ZVbU4yendnVUxIdXFwdDhaSjlfRUlFTUhGNmNBTlRtdUlxWEFtT1BzbFRieW9yWTFUNm9XUTl2Vzc3WEJWMkY3NmZwSGxJOTdQUzFaUkFnR21XVGh4UkttNEpLc28?oc=5","date":"2024-11-15","type":"regulatory","source":"fda.gov","summary":"QOL Medical and Its CEO Agree To Pay $47 Million for Alleged Kickbacks - fda.gov","headline":"QOL Medical and Its CEO Agree To Pay $47 Million for Alleged Kickbacks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwJBVV95cUxNSWRWTHhRVHdNMDBWNTBvMlAwNUw0V2lxOTlwa2lyLXZRbEl4Z0NMTFFMUVRWckl0X1FTbVZ0YWdjS21uSkFScmRyV25iNEo5MWZnREIzaXQwcmI4LUh4dUYtdUgxN01mR25nZmVfMlFyekE3WUdsR01WbWZ4dWNUU2hsSGpxdm5Oam54Wm03LW82Zi1vcUNTUWpDSWx5RnBfb1RJclc5Q29ONHlWMjVkXzVReE5ITHBkc2k3UDZ4ZFAydFZOa3hOblBtcXEydkNpcVBpcGRIYk9CakNHdzEzMlhxNE9UT01NS1gzaEVQRUpPLW9VVUhNdmxSYk0ybFFpZDIzb0M5LWtCY3NiUE1TUnNjSQ?oc=5","date":"2022-09-06","type":"regulatory","source":"BioSpace","summary":"QOL Medical, LLC receives FDA approval of Sucraid® (sacrosidase) Oral Solution single-use containers for patients with Congenital Sucrase-Isomaltase Deficiency (CSID) - BioSpace","headline":"QOL Medical, LLC receives FDA approval of Sucraid® (sacrosidase) Oral Solution single-use containers for patients with C","sentiment":"positive"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}